The Top Growth Stocks, Ranked by Seeking Alpha Analyst Ratings
Further Weakness as LivaNova (NASDAQ:LIVN) Drops 5.3% This Week, Taking Three-year Losses to 37%
For many investors, the main point of stock picking is to generate higher returns than the overall market. But its virtually certain that sometimes you will buy stocks that fall short of the market
Mizhuo's Top Picks in Healthcare for July
LivaNova (NASDAQ:LIVN) Is Doing The Right Things To Multiply Its Share Price
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) an
LivaNova to Announce Second-Quarter 2024 Results
Jefferies Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $90
Jefferies analyst Matthew Taylor maintains $LivaNova(LIVN.US)$ with a buy rating, and maintains the target price at $90.According to TipRanks data, the analyst has a success rate of 60.3% and a total
Barclays Maintains LivaNova(LIVN.US) With Hold Rating, Maintains Target Price $61
Barclays analyst Matt Miksic maintains $LivaNova(LIVN.US)$ with a hold rating, and maintains the target price at $61.According to TipRanks data, the analyst has a success rate of 62.3% and a total ave
Sector Update: Health Care Stocks Advance Thursday Afternoon
Health care stocks rose Thursday afternoon with the NYSE Health Care Index rising 0.2% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%. The iShares Biotechnology ETF (IBB) eased 0.2%. In cor
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of G-III Apparel Group, Ltd. (NASDAQ:GIII) fell sharply during Thursday's session after the company reported worse-than-expected quarterly sales results.G-III Apparel Group posted adjusted earn
Needham Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $72
Needham analyst Michael Matson maintains $LivaNova(LIVN.US)$ with a buy rating, and maintains the target price at $72.According to TipRanks data, the analyst has a success rate of 43.4% and a total av
Express News | Needham Reiterates Buy on LivaNova, Maintains $72 Price Target
LivaNova Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/06/2024 34.59% Needham $72 → $72 Reiterates Buy → Buy 05/02/2024 49.55% Mizuho $75 → $80 Maintains Buy
LivaNova Down Nearly 12%, on Pace for Largest Percent Decrease Since May 2022 -- Data Talk
LivaNova Plc (LIVN) is currently at $52.86, down $7.18 or 11.95% --Would be lowest close since April 19, 2024, when it closed at $52.33 --On pace for largest percent decrease since May 5, 2022, when
LivaNova Stock Slips 11% After VNS Therapy Study Fails To Meet Primary Endpoint
Express News | LivaNova Shares Are Trading Lower After the Company's RECOVER Clinical Study Did Not Meet Its Primary Endpoint for the Unipolar Cohort, Though Statistical Significance Was Achieved in Select Secondary Endpoints
Express News | LivaNova's RECOVER Clinical Study Did Not Meet Its Primary Endpoint For The Unipolar Cohort, Says Statistical Significance Was Achieves In Select Secondary Endpoints
Express News | LivaNova : Expects to Publish Unipolar Cohort Data Including Details on Pe and Secondary Endpoints, in Peer-Reviewed Journals in Q4 2024
Express News | LivaNova PLC: Statistically Significant and Clinically Meaningful Benefits Seen in Select Secondary Endpoints; No Safety Concerns Identified
Express News | LivaNova PLC: Primary Endpoint Did Not Achieve Statistical Significance in Unipolar Patient Cohort
Express News | LivaNova Provides Update on Recover Clinical Study Evaluating Vns Therapy for Treatment-Resistant Depression in Unipolar Patients